ZDGE

Zedge Inc

2.95

Sep 29 • 3:59 PM ET -0.14 (-4.53%)

3.06

Aftermarket • 7:47 PM ET +0.11 (3.73%)

Communication Services Internet Content & Information USA Nano AMEX

Peers: BZFD IZEA PAAI SJ SOGP BODI TEAD TZOO WSHP DIBS

| Held by: VTI VXF IWC BUSM DFMC DFAS DCOR DXUV DFAC DFSU

Index	-
Market Cap	38.55M
Enterprise Value	19.05M
Income	-1.13M
Sales	31.32M
Book/sh	1.88
Cash/sh	1.51
Dividend Est.	-
Dividend TTM	0.07 (2.44%)
Dividend Ex-Date	Jun 22, 2026
Dividend Gr. 3/5Y	- -
Payout	-
Employees	82
IPO	May 26, 2016

P/E	-
Forward P/E	16.39
PEG	0.29
P/S	1.23
P/B	1.57
P/C	1.96
P/FCF	12.44
EV/EBITDA	5.57
EV/Sales	0.61
Quick Ratio	3.21
Current Ratio	3.21
Debt/Eq	0.01
LT Debt/Eq	0.00
Option/Short	Yes / Yes

EPS (ttm)	-0.09
EPS next Y	0.18
EPS next Q	0.02
EPS this Y	-120.00%
EPS next Y	1900.00%
EPS next 5Y	56.05%
EPS past 3/5Y	- -28.24%
Sales past 3/5Y	3.46% 25.43%
EPS Y/Y TTM	35.52%
Sales Y/Y TTM	6.14%
EPS Q/Q	424.81%
Sales Q/Q	3.03%
Earnings	Jun 11 AMC
EPS/Sales Surpr.	40.00% 14.29%

Insider Own	23.46%
Insider Trans	0.00%
Inst Own	18.66%
Inst Trans	4.23%
ROA	-3.14%
ROE	-4.26%
ROIC	-4.62%
Gross Margin	90.72%
Oper. Margin	8.50%
Profit Margin	-3.62%
SMA20	-2.48%
SMA50	-1.11%
SMA200	-5.21%
Trades

Shs Outstand	12.52M
Shs Float	10.00M
Short Float	0.67%
Short Ratio	0.82
Short Interest	0.07M
52W High	4.70 -37.23%
52W Low	2.21 33.48%
Volatility	3.90% 4.31%
ATR (14)	0.12
RSI (14)	45.60
Beta	1.18
Rel Volume	1.03
Avg Volume	81.22K
Volume	83,888

Perf Week	-3.91%
Perf Month	2.79%
Perf Quarter	-4.84%
Perf Half Y	6.88%
Perf YTD	-10.06%
Perf Year	0.00%
Perf 3Y	34.70%
Perf 5Y	-77.34%
Perf 10Y	-22.16%
Recom	1.00
Target Price	6.00
Prev Close	3.09
Price	2.95
Change %	-4.53%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-16-21	Reiterated	Maxim Group	Buy	$19 → $24
Feb-11-21	Initiated	Maxim Group	Buy	$19
Jun-25-20	Initiated	National Securities	Buy	$3

Aug-31-26 06:30AM	Zedge Accelerates DataSeeds.AI Strategy with $7.5 Million Insider Investment and Appointment of Morris Berger as CEO (ACCESSWIRE) +5.92%
Jun-17-26 04:10PM	Zedge's Tapedeck Adds Betty Wright's Catalog in Agreement With the Late Soul Legend's Estate (ACCESSWIRE)
Jun-12-26 01:00AM	Zedge Inc (ZDGE) Q3 2026 Earnings Call Highlights: Strong Subscription Growth and Strategic ... (GuruFocus.com) +25.68%
Jun-11-26 08:20PM	Zedge, Inc. Q3 2026 Earnings Call Summary (Moby) +6.09%
04:10PM	Zedge Reports Third Quarter Fiscal 2026 Results (ACCESSWIRE)
06:30AM	Loading…
Jun-01-26 06:30AM	Zedge To Report Third Fiscal Quarter 2026 Results (ACCESSWIRE) +9.09%
May-28-26 06:30AM	Zedge to Present at The Planet Microcap Las Vegas 2026 Conference Powered by Microcap Club (ACCESSWIRE)
Mar-25-26 06:30AM	Zedge Increases Quarterly Cash Dividend by 25% (ACCESSWIRE)
Mar-13-26 08:30AM	Zedge, Inc. Q2 2026 Earnings Call Summary (Moby) -14.47%
Mar-12-26 11:06PM	Zedge Inc (ZDGE) Q2 2026 Earnings Call Highlights: Record Revenue and Subscriber Growth Amid ... (GuruFocus.com)
04:10PM	Zedge Reports Second Quarter Fiscal 2026 Results (ACCESSWIRE)
Mar-03-26 06:30AM	Zedge To Report Second Quarter 2026 Results (ACCESSWIRE)
Jan-31-26 03:56PM	From Buybacks to Dividends: Zedge (ZDGE) Deepens Shareholder Focus (Insider Monkey)
Dec-12-25 06:00PM	Zedge Inc (ZDGE) Q1 2026 Earnings Call Highlights: Strong Subscription Growth and Financial ... (GuruFocus.com) +14.40%
06:30AM	Zedge Reports First Quarter Fiscal 2026 Results (ACCESSWIRE)
06:30AM	Loading…
Dec-02-25 06:30AM	Zedge To Report First Fiscal Quarter 2026 Results (ACCESSWIRE)
Oct-30-25 03:21PM	Zedge Inc (ZDGE) Q4 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth ... (GuruFocus.com) -5.30%
Oct-28-25 06:30AM	Zedge Reports Fourth Quarter and Full Year Fiscal 2025 Results (ACCESSWIRE) -24.27%
Oct-24-25 08:07AM	Zedge Launches New Creator-Focused Music App 'Tapedeck' for Fair Artist Compensation (Insider Monkey) +6.53%
Oct-20-25 07:00AM	Zedge's Dataseeds.AI Grows its Enterprise Customer Base for Rights-Cleared, On-Demand Visual Datasets (ACCESSWIRE)
06:10AM	Zedge To Report Fourth Quarter & End of Fiscal Year 2025 Results (ACCESSWIRE)
Oct-14-25 06:30AM	Zedge Announces Initiation of Quarterly Cash Dividend (ACCESSWIRE)
Oct-09-25 07:00AM	Zedge Introduces its AI-Powered Product Innovation Team to Drive New Growth (ACCESSWIRE)
Oct-06-25 06:30AM	Zedge Launches Tapedeck: A Bold New Platform Putting the Power - and the Payout - Back in Artists' Hands (ACCESSWIRE) +6.29%
Jul-17-25 06:30AM	Zedge's Emojipedia Celebrates World Emoji Day 2025 with Launch of Digital Stickers Vertical (ACCESSWIRE)
Jun-14-25 09:00AM	Morning Movers: Meta Platforms dips following big investment in Scale AI (TipRanks)
Jun-13-25 03:02AM	Zedge Inc (ZDGE) Q3 2025 Earnings Call Highlights: Revenue Growth and Strategic Initiatives ... (GuruFocus.com)
Jun-12-25 04:10PM	Zedge Announces Third Quarter Fiscal 2025 Results (ACCESSWIRE)
Jun-11-25 09:17AM	Zedge Inc (ZDGE) Q3 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Jun-09-25 06:30AM	Zedge's DataSeeds.AI Releases Foundational Dataset for Computer Vision and Generative AI in Collaboration with Perle.ai and Emet Research (ACCESSWIRE)
06:30AM	Loading…
Jun-05-25 06:30AM	Zedge Launches DataSeeds.AI, a Content Marketplace for AI Training Sets (ACCESSWIRE) +7.20%
Jun-02-25 06:30AM	Zedge to Participate in the "2025 Virtual Tech Conference: Discover the Innovations Reshaping Tomorrow" Virtual Conference Presented by Maxim Group (ACCESSWIRE)
May-30-25 06:30AM	Zedge To Report Third Fiscal Quarter 2025 Results (ACCESSWIRE)
Mar-13-25 03:07AM	Zedge Inc (ZDGE) Q2 2025 Earnings Call Highlights: Navigating Revenue Challenges with Strategic ... (GuruFocus.com)
Mar-12-25 04:10PM	Zedge Announces Second Quarter Fiscal 2025 Results (ACCESS Newswire) -5.31%
Mar-03-25 06:30AM	Zedge To Report Second Fiscal Quarter 2025 Results (ACCESS Newswire)
Feb-05-25 06:30AM	Zedge Increases Cost Reduction Efforts to a Targeted $4 Million Annually (ACCESS Newswire) +10.73%
Jan-21-25 06:30AM	Zedge Announces GuruShots Restructuring to Improve Profitability and Position Itself for Long-term Growth (ACCESS Newswire)
Dec-17-24 02:00AM	Zedge Inc (ZDGE) Q1 2025 Earnings Call Highlights: Subscription Growth and Strategic Challenges (GuruFocus.com)
01:11AM	Q1 2025 Zedge Inc Earnings Call (Thomson Reuters StreetEvents)
Dec-16-24 06:30AM	Zedge Announces First Quarter Fiscal 2025 Results (ACCESSWIRE) -15.75%
Dec-13-24 07:02AM	Zedge Inc (ZDGE) Q1 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Dec-05-24 04:10PM	Zedge To Report First Fiscal Quarter 2025 Results (ACCESS Newswire)
Dec-02-24 06:30AM	Emojipedia Launches Free AI-Powered Emoji Creator (ACCESSWIRE)
Nov-13-24 06:30AM	Zedge Marketplace Introduces Major Website Updates (ACCESSWIRE)
Oct-30-24 04:59AM	Q4 2024 Zedge Inc Earnings Call (Thomson Reuters StreetEvents)
03:10AM	Zedge Inc (ZDGE) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Operational Challenges (GuruFocus.com)
Oct-29-24 06:30AM	Zedge Announces Fourth Quarter and Full Year Fiscal 2024 Results (ACCESSWIRE)
Oct-28-24 09:09AM	Earnings To Watch: Zedge Inc (ZDGE) Reports Q4 2024 Result (GuruFocus.com)
Oct-23-24 06:30AM	Zedge's GuruShots Photography Game Introduces Exciting New Features: Onboarding, Missions and Enhanced Game Economy (ACCESSWIRE)
Oct-22-24 06:30AM	Zedge To Report Fourth Quarter And End Of Year Fiscal 2024 Results (ACCESSWIRE)
Oct-17-24 02:08PM	Zedge Announces Participation in the LD Micro Main Event XVII (Newsfile)
Sep-17-24 06:30AM	Zedge Unveils Significant Enhancements to its Gen AI Creation Tool for iOS (ACCESSWIRE)
Sep-16-24 06:30AM	Zedge Announces New $5 Million Share Repurchase Program (ACCESSWIRE) +5.35%
Sep-13-24 06:30AM	Zedge to Participate in the Maxim Group 2024 Gaming, Media & Entertainment Virtual Conference (ACCESSWIRE)
Sep-12-24 06:30AM	Zedge Marketplace Data Reveals Strong Consumer Preference for AI-Generated Content (ACCESSWIRE)
Jul-17-24 06:30AM	Zedge and Emojipedia Celebrate World Emoji Day by Introducing The "Emoji Playground" (ACCESSWIRE)
Jun-11-24 10:01AM	Zedge, Inc. (AMEX:ZDGE) Q3 2024 Earnings Call Transcript (Insider Monkey) +12.62%
Jun-10-24 04:10PM	Zedge Announces Third Quarter Fiscal 2024 Results (ACCESSWIRE)
Jun-03-24 06:30AM	Zedge To Report Third Fiscal Quarter 2024 Results (ACCESSWIRE)
May-30-24 06:30AM	Zedge to Join the Russell Microcap Index (ACCESSWIRE)
May-02-24 06:35AM	3 Penny Stocks to Buy Now to Turn $1K Into $133K by 2026 (InvestorPlace)
Mar-27-24 07:00AM	Zedge to Present at The LD Micro Invitational XIV (Newsfile)
Mar-25-24 06:30AM	Zedge to Present at The LD Micro Invitational XIV (ACCESSWIRE) -7.72%
Mar-16-24 09:50AM	Zedge, Inc. (AMEX:ZDGE) Q2 2024 Earnings Call Transcript (Insider Monkey)
12:24AM	Q2 2024 Zedge Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-15-24 06:30AM	Zedge Announces Second Quarter Fiscal 2024 Results (ACCESSWIRE) -18.80%
Mar-08-24 06:30AM	Zedge To Report Second Fiscal Quarter 2024 Results (ACCESSWIRE)
Dec-19-23 08:19AM	Zedge, Inc. (AMEX:ZDGE) Q1 2024 Earnings Call Transcript (Insider Monkey)
Dec-14-23 06:27AM	Q1 2024 Zedge Inc Earnings Call (Thomson Reuters StreetEvents)
Dec-13-23 04:10PM	Zedge Announces First Quarter Fiscal 2024 Results (ACCESSWIRE) +9.50%
Dec-06-23 06:30AM	Zedge to Report First Fiscal Quarter 2024 Results (ACCESSWIRE)
Dec-04-23 06:30AM	Zedge Uses Cash Flow From Operations For Early Pay Off of Outstanding Debt (ACCESSWIRE) +11.11%
Nov-14-23 08:55AM	Sidoti Events, LLCs Virtual November Micro-Cap Conference (ACCESSWIRE) +7.91%
Nov-08-23 06:30AM	Zedge Announces Participation in Sidoti MicroCap Virtual Conference on November 15 and 16, 2023 (ACCESSWIRE)
Oct-27-23 10:07AM	Zedge, Inc. (AMEX:ZDGE) Q4 2023 Earnings Call Transcript (Insider Monkey) -7.69%
09:11AM	Q4 2023 Zedge Inc Earnings Call (Thomson Reuters StreetEvents)
Oct-26-23 06:08PM	Zedge Inc (ZDGE) Reports Q4 and Full-Year Fiscal 2023 Results (GuruFocus.com)
04:10PM	Zedge Announces Fourth Quarter and Full-Year Fiscal 2023 Results (ACCESSWIRE)
Oct-19-23 06:30AM	Zedge to Report Fiscal Fourth Quarter & Year End 2023 Results (ACCESSWIRE)
Sep-25-23 08:30AM	iAccess Alpha Best Ideas from the Buyside Virtual Conference - Sep 26th-27th 2023 (ACCESSWIRE)
Sep-22-23 03:05PM	Maxim Group LLC to Host the Virtual Tech Conference Series: Emerging Growth in A.I., on Tuesday, September 26th & Wednesday, September 27th at 8:00 A.M. ET. (GlobeNewswire)
Sep-19-23 06:30AM	Zedge Announces Participation in Upcoming Investor Conferences on September 26, 2023 (ACCESSWIRE)
Sep-13-23 12:12PM	3 Metaverse Stocks to Sell in September Before They Crash & Burn (InvestorPlace)
Jul-17-23 06:30AM	Zedge Celebrates World Emoji Day's Tenth Anniversary Year with Exciting Initiatives (ACCESSWIRE)
Jun-16-23 12:21PM	Zedge, Inc. (AMEX:ZDGE) Q3 2023 Earnings Call Transcript (Insider Monkey)
Jun-13-23 05:47AM	Q3 2023 Zedge Inc Earnings Call (Thomson Reuters StreetEvents)
Jun-12-23 04:10PM	Zedge Announces Third Quarter Fiscal 2023 Results (ACCESSWIRE) +8.25%
Jun-05-23 06:30AM	Zedge to Report Third Quarter 2023 Results (ACCESSWIRE)
Apr-04-23 06:30AM	Nyla Hayes, Famed Teenage Digital Artist, Partners with Zedge Premium to Offer Her Long Neckie Vibes On the Go (ACCESSWIRE)
Mar-18-23 03:12AM	Zedge, Inc. (AMEX:ZDGE) Q2 2023 Earnings Call Transcript (Insider Monkey)
Mar-16-23 06:00AM	Q2 2023 Zedge Inc Earnings Call (Thomson Reuters StreetEvents) -14.23%
Mar-15-23 04:10PM	Zedge Announces Second Quarter Fiscal 2023 Results (ACCESSWIRE)
Mar-14-23 05:00AM	Big Potential Profit Plays In The Gaming Stocks Sector (News Direct)
Mar-09-23 06:30AM	Zedge to Report Second Quarter 2023 Results (ACCESSWIRE)
Dec-22-22 11:02AM	Zedge, Inc. (AMEX:ZDGE) Q4 2022 Earnings Call Transcript (Insider Monkey)
Dec-16-22 08:50AM	Zedge, Inc. (AMEX:ZDGE) Q1 2023 Earnings Call Transcript (Insider Monkey)
Dec-13-22 04:10PM	Zedge Announces First Quarter Fiscal 2023 Results (ACCESSWIRE) -6.93%
10:25AM	Zedge to Report First Quarter 2023 Results (ACCESSWIRE)
Dec-12-22 06:30AM	Zedge Enables Monetziation of GuruShots Player's Photos in Zedge Marketplace (ACCESSWIRE)

Zedge, Inc. engages in the provision of digital marketplace, games, and content platforms. It operates through the following segments: Zedge Marketplace and GuruShots. The company was founded by Tom Arnoy in 2008 and is headquartered in New York, NY.

Executive Chairman of the BoardMr. Michael C. Jonas

CEO & PresidentMr. Jonathan Reich

CFO & TreasurerMr. Yi Tsai CPA

Corporate SecretaryMs. Joyce J. Mason Esq.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
REICH JONATHAN	CEO & President	Sep 25 '26	Option Exercise	2.27	60,000	136,200	143,417	Sep 29 06:40 PM
REICH JONATHAN	CEO & President	May 29 '26	Option Exercise	1.73	181,616	314,196	211,507	Jun 02 04:26 PM

Open in Screener

RFL

Rafael Holdings Inc

2.03

Sep 29 • 3:59 PM ET +0.01 (0.50%)

2.12

Aftermarket • 7:30 PM ET +0.09 (4.43%)

Real Estate Real Estate Services USA Micro NYSE

RFL Rafael Holdings Inc daily Stock Chart

Peers: ASPS MAYS STHO DOUG SRG CHCI NEN EUDA NMRK MMI

| Held by: VTI VXF IWC DFMC DFAS DXUV DCOR DFAC AVSC DFUS

Index	-
Market Cap	105.58M
Enterprise Value	81.11M
Income	-32.55M
Sales	0.98M
Book/sh	1.45
Cash/sh	0.59
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	23
IPO	Mar 27, 2018

P/E	-
Forward P/E	-
PEG	-
P/S	107.73
P/B	1.40
P/C	3.46
P/FCF	-
EV/EBITDA	-
EV/Sales	82.77
Quick Ratio	3.14
Current Ratio	3.16
Debt/Eq	0.01
LT Debt/Eq	0.00
Option/Short	Yes / Yes

EPS (ttm)	-0.68
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	44.95% -9.76%
Sales past 3/5Y	30.78% -28.51%
EPS Y/Y TTM	26.75%
Sales Y/Y TTM	33.88%
EPS Q/Q	55.81%
Sales Q/Q	-50.55%
Earnings	Mar 16 AMC
EPS/Sales Surpr.	- -

Insider Own	32.60%
Insider Trans	0.00%
Inst Own	7.50%
Inst Trans	4.77%
ROA	-32.54%
ROE	-41.74%
ROIC	-43.18%
Gross Margin	74.39%
Oper. Margin	-3717.24%
Profit Margin	-3321.73%
SMA20	-7.20%
SMA50	-4.57%
SMA200	21.77%
Trades

Shs Outstand	51.21M
Shs Float	35.05M
Short Float	2.26%
Short Ratio	5.05
Short Interest	0.79M
52W High	3.96 -48.74%
52W Low	1.12 81.25%
Volatility	8.58% 9.03%
ATR (14)	0.19
RSI (14)	44.11
Beta	0.31
Rel Volume	0.54
Avg Volume	156.56K
Volume	85,291

Perf Week	1.50%
Perf Month	-20.70%
Perf Quarter	-38.11%
Perf Half Y	66.39%
Perf YTD	72.03%
Perf Year	48.18%
Perf 3Y	7.46%
Perf 5Y	-93.85%
Perf 10Y	-
Recom	-
Target Price	-
Prev Close	2.02
Price	2.03
Change %	0.50%

Jun-23-26 12:10PM	Israel said to eye US listing for major defense firms (Investing.com)
Jun-11-26 07:30AM	Rafael Holdings Reports Third Quarter Fiscal 2026 Financial Results (GlobeNewswire) +19.10%
Jun-10-26 07:30AM	Rafael Holdings Announces Completion of Last Patient Last Visit for Pivotal Phase 3 TransportNPC Study Evaluating Trappsol Cyclo for the Treatment of Niemann-Pick Disease Type C (GlobeNewswire) -7.77%
Apr-22-26 07:00AM	Rafael Holdings Announces Patent Licensing Agreement with MIT for "Small Molecules to Improve Myelination in ApoE4 positive Alzheimer's Disease" (GlobeNewswire)
Mar-16-26 04:01PM	Rafael Holdings Reports Second Quarter Fiscal 2026 Financial Results (GlobeNewswire)
04:01PM	Loading…
Dec-11-25 04:01PM	Rafael Holdings Reports First Quarter Fiscal 2026 Financial Results (GlobeNewswire)
Oct-29-25 04:24PM	Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results (GlobeNewswire)
Oct-28-25 04:01PM	Rafael Holdings Mourns the Passing of Lead Independent Director, Stephen Greenberg, and Announces the Appointment of Alan Grayson to its Board of Directors (GlobeNewswire)
Sep-16-25 08:00AM	Rafael Holdings Announces Presentation of Preliminary Data from Ongoing Phase 3 TransportNPC Open-Label, Single-Arm Sub-Study in Patients Less Than 3 Years Old (GlobeNewswire) +6.77%
Aug-27-25 08:00AM	Rafael Holdings Announces Abstracts Accepted for Oral and Poster Presentations at the 15th International Congress of Inborn Errors of Metabolism (ICIEM) (GlobeNewswire)
Jun-18-25 07:00AM	Rafael Holdings Announces Continuation of its Phase 3 Study for the Treatment of Niemann-Pick Disease Type C1 (NPC1) Following Independent Data Monitoring Committee (DMC) Review of Prespecified 48-Week Interim Data (GlobeNewswire) -19.07%
Jun-11-25 07:00AM	Rafael Holdings Reports Third Quarter Fiscal 2025 Financial Results (GlobeNewswire) -27.72%
Jun-04-25 04:01PM	Rafael Holdings, Inc. Announces Final Results and Closing of Rights Offering (GlobeNewswire) +12.68%
May-20-25 04:01PM	Rafael Holdings, Inc. Provides Update to the Description of Subscription Rights Related to its Public Warrants in Connection With its Previously Announced $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol Cyclo (GlobeNewswire)
May-05-25 07:00AM	Rafael Holdings, Inc. Announces Revised Subscription Rights in Connection With its Previously Announced $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol Cyclo (GlobeNewswire) -7.14%
04:30PM	Loading…
Apr-29-25 04:30PM	Rafael Holdings, Inc. Announces Proposed Terms of a $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol Cyclo (GlobeNewswire) -5.95%
Apr-24-25 04:15PM	Rafael Holdings Strengthens its Focus on the Development of Trappsol Cyclo and Announces Chief Executive Officer Bill Conkling Will Be Stepping Down from His Role (GlobeNewswire)
Mar-26-25 06:50AM	Rafael Holdings Completes Merger with Cyclo Therapeutics Following Shareholder Approvals (GlobeNewswire)
Mar-13-25 05:50PM	Rafael Holdings Reports Second Quarter Fiscal 2025 Financial Results (GlobeNewswire)
Dec-11-24 07:00AM	Rafael Holdings Reports First Quarter Fiscal 2025 Financial Results (GlobeNewswire)
Nov-06-24 07:14PM	Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results (GlobeNewswire)
Aug-22-24 06:50AM	Rafael Holdings and Cyclo Therapeutics Enter into a Definitive Merger Agreement (GlobeNewswire)
Jun-14-24 04:01PM	Rafael Holdings Reports Third Quarter Fiscal 2024 Financial Results (GlobeNewswire)
May-30-24 09:00AM	Cyclo Therapeutics Achieves Landmark Milestone with Completion of Enrollment of Last Patient in Phase 3 Pivotal TransportNPC Trial of Niemann-Pick Type C1 (Business Wire)
Mar-13-24 05:04PM	Rafael Holdings Reports Second Quarter Fiscal 2024 Financial Results (GlobeNewswire)
Dec-14-23 10:51PM	RFL Stock Earnings: Rafael Holdings Reported Results for Q1 2024 (InvestorPlace)
04:01PM	Rafael Holdings Reports First Quarter Fiscal 2024 Financial Results (GlobeNewswire)
Nov-15-23 08:05AM	Cyclo Therapeutics Reports Third Quarter 2023 Financial Results (Business Wire)
Oct-30-23 04:01PM	Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2023 Financial Results (GlobeNewswire) +10.97%
Aug-15-23 08:05AM	Cyclo Therapeutics Reports Second Quarter 2023 Financial Results (Business Wire)
08:16AM	Loading…
Aug-02-23 08:16AM	Cyclo Therapeutics Announces Closing of $5.0 Million Private Placement with Rafael Holdings, Inc. (Business Wire)
Jun-13-23 04:01PM	Rafael Holdings Reports Third Quarter Fiscal 2023 Financial Results and Provides Business Update (GlobeNewswire) +7.32%
Jun-05-23 08:05AM	Cyclo Therapeutics Announces Execution of Definitive Agreement with Rafael Holdings, Inc. Providing for $5.0 Million of Additional Funding Via a Private Placement (Business Wire)
May-15-23 08:05AM	Cyclo Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results (Business Wire)
May-02-23 08:12AM	Cyclo Therapeutics Announces Closing of Strategic Investment Through a $2.1 Million Private Placement from Rafael Holdings, Inc. (NYSE:RFL) (Business Wire)
Apr-04-23 08:00AM	Rafael Holdings Announces up to $5 Million Share Repurchase Program (GlobeNewswire) +17.68%
Mar-14-23 04:01PM	Rafael Holdings Reports Second Quarter Fiscal 2023 Financial Results (GlobeNewswire) -8.72%
Dec-13-22 07:00AM	Rafael Holdings Reports First Quarter Fiscal 2023 Financial Results (GlobeNewswire)
Nov-15-22 04:01PM	Rafael Holdings to Focus on Strategic Business Development Initiatives and Curtail Early Stage Development Activities (GlobeNewswire) +6.52%
Oct-31-22 04:01PM	Rafael Holdings Reports Fourth Quarter Fiscal 2022 Financial Results (GlobeNewswire) +9.04%
Sep-28-22 07:00AM	Cornerstone Pharmaceuticals Initiates Phase 1 Trial of CPI-613® (devimistat) in Combination with Chemoradiation for the Treatment of Advanced Pancreatic Cancer (GlobeNewswire)
Aug-23-22 07:43AM	Rafael Holdings Sells its Building Located at 520 Broad Street in Newark, New Jersey and Associated 800-Car Public Garage (GlobeNewswire)
Aug-03-22 08:00AM	Cornerstone Pharmaceuticals Announces Successful Completion of Phase 1b Clinical Trial for CPI-613® (Devimistat) in Combination with Gemcitabine and Cisplatin in Patients with Biliary Tract Cancer (GlobeNewswire)
Jul-10-22 08:08AM	Howard Jonas Is The Founder & Chairman of Rafael Holdings, Inc. (NYSE:RFL) And They Just Picked Up 83% More Shares (Simply Wall St.)
Jul-06-22 08:00AM	Cornerstone Pharmaceuticals Strengthens Scientific Advisory Board with the Appointment of Distinguished Scholar Jason Locasale, Ph.D. (GlobeNewswire) -5.88%
Jun-27-22 08:00AM	Cornerstone Pharmaceuticals to Present Pancreatic Cancer Data on CPI-613® (Devimistat) From Its Open-Label Phase 1 Study at the European Society of Medical Oncology (ESMO) World Congress on Gastrointestinal Cancer 2022 (GlobeNewswire)
Jun-16-22 02:14PM	Cornerstone Pharmaceuticals Announces Published Data on CPI-613® (Devimistat) as an Effective Approach to Targeting Carcinoma Catabolism UPDATE (GlobeNewswire)
08:00AM	Cornerstone Pharmaceuticals Announces Published Data on CPI-613® (Devimistat) as an Effective Approach to Targeting Carcinoma Catabolism (GlobeNewswire)
Jun-14-22 04:01PM	Rafael Holdings Reports Third Quarter Fiscal 2022 Financial Results (GlobeNewswire) -5.88%
Jun-01-22 08:00AM	Cornerstone Pharmaceuticals to Present Pancreatic Cancer, Clear Cell Sarcoma and Biliary Tract Cancer Research Featuring CPI-613® (Devimistat) at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting (GlobeNewswire)
May-24-22 11:04AM	European Medicines Agency Grants Orphan Drug Designation to Cornerstone Pharmaceuticals CPI-613® (Devimistat) for Treatment of Patients with Advanced Unresectable Biliary Tract Cancer (GlobeNewswire)
May-19-22 09:00AM	Rafael Pharmaceuticals, Inc. Announces Corporate Name Change to Cornerstone Pharmaceuticals, Inc. (GlobeNewswire)
Mar-17-22 04:01PM	Rafael Holdings Reports Second Quarter Fiscal 2022 Financial Results (GlobeNewswire) +18.22%
Feb-17-22 12:32PM	Rafael Holdings, Inc. (NYSE:RFL) insider upped their holding by 4.1% earlier this year (Simply Wall St.) -8.61%
Jan-24-22 01:38PM	SkyOak Wealth, LLC Buys iShares Russell 2000 Growth ETF, Vanguard S&P 500 ETF, Vanguard ... (GuruFocus.com)
Jan-21-22 07:00AM	William Bill Conkling to assume the role of Chief Executive Officer as of February 1, 2022 (GlobeNewswire)
Jan-19-22 09:38AM	Adirondack Retirement Specialists, Inc. Buys IDT Corp, Camping World Holdings Inc, Semler ... (GuruFocus.com)
Jan-18-22 08:30AM	Rafael Pharmaceuticals Announces Ongoing Successful Enrollment and Opening of Additional Sites for Phase 2 Clinical Trial of CPI-613® (Devimistat) in Combination with Gemcitabine and Cisplatin in Patients with Biliary Tract Cancer (GlobeNewswire) -8.05%
Jan-06-22 08:30AM	Rafael Pharmaceuticals Announces Successful Completion of Dose Escalation with No Dose-Limiting Toxicity (DLT) in First Cohort of APOLLO 613 Phase 1/2 Clinical Trial of CPI-613® (Devimistat) in Patients with Relapsed Clear Cell Sarcoma (GlobeNewswire)
Dec-17-21 09:40AM	Is Rafael Holdings (NYSE:RFL) Using Too Much Debt? (Simply Wall St.)
Dec-15-21 04:30PM	Rafael Holdings Reports First Quarter Fiscal 2022 Financial and Operating Results (GlobeNewswire)
Dec-13-21 08:00AM	Rafael Pharmaceuticals Announces Published Data on CPI-613® (Devimistat) From Phase 2 Clinical Trial for Refractory Burkitt Lymphoma at the 2021 American Society of Hematology (ASH) Annual Meeting and Exposition (GlobeNewswire)
Nov-22-21 07:00AM	Rafael Holdings Realigns Leadership Team to Support Earlier Stage Pipeline Focus (GlobeNewswire) -7.41%
Nov-11-21 09:00AM	Rafael Pharmaceuticals Announces First Patient Enrolled in APOLLO 613 Phase 1/2 Clinical Trial of CPI-613® (Devimistat) in Patients with Relapsed Clear Cell Sarcoma (GlobeNewswire)
Nov-03-21 09:00AM	European Medicines Agency Grants Orphan Drug Designation to Rafael Pharmaceuticals CPI-613® (Devimistat) for Treatment of Patients with Relapsed or Refractory Burkitt's Lymphoma (GlobeNewswire) +5.26%
Oct-29-21 11:00AM	Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Rafael Holdings, Inc. (RFL) Investigation (ACCESSWIRE) -6.55%
Oct-28-21 08:00AM	Rafael Pharmaceuticals Provides Update on Pivotal Phase 3 Clinical Trial in Patients with Metastatic Pancreatic Cancer and Interim Analysis of Pivotal Phase 3 Clinical Trial in Patients with Relapsed or Refractory Acute Myeloid Leukemia (GlobeNewswire) -73.19%
07:00AM	Rafael Holdings Provides Update on Rafael Pharmaceuticals Two Phase 3 Trials of CPI-613® (Devimistat), AVENGER 500 in Metastatic Pancreatic Cancer and ARMADA 2000 in Relapsed or Refractory Acute Myeloid Leukemia (GlobeNewswire)
Oct-25-21 03:05PM	Investing in Rafael Holdings (NYSE:RFL) three years ago would have delivered you a 271% gain (Simply Wall St.)
Oct-20-21 02:17AM	SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates GTS, RFL, ACBI, HOMB; Shareholders are Encouraged to Contact the Firm (PR Newswire)
Oct-18-21 05:41PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation into the Fairness of the Merger of Rafael Holdings, Inc. with Rafael Pharmaceuticals, Inc. (Newsfile)
05:30PM	Rafael Holdings Announces Inducement Grant Under NYSE Rule 303A.08 (GlobeNewswire)
04:30PM	Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2021 Financial and Operating Results and Provides Business Update (GlobeNewswire)
Oct-13-21 03:32PM	SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates COLB, ESXB, RFL, CLDB, VICI; Shareholders are Encouraged to Contact the Firm (PR Newswire)
Oct-12-21 01:45PM	MERGER ALERT - INOV, and RFL: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies (ACCESSWIRE)
Oct-06-21 06:30AM	Rafael Holdings Appoints Mimi Huizinga, MD, MPH as Chief Development and Medical Officer (PR Newswire) +6.09%
Sep-27-21 08:00AM	Rafael Pharmaceuticals Announces APOLLO613 Phase I/II Clinical Trial of CPI-613® (devimistat) in Combination with Hydroxychloroquine in Patients with Relapsed Clear Cell Sarcoma Begins Enrollment at City of Hope in Duarte, Calif. (GlobeNewswire)
Sep-24-21 04:30PM	Rafael Holdings Continues to Expand its Management Team with a Highly Experienced Global Biopharmaceutical Executive to Build a Fully Integrated Cancer Metabolism Therapeutics Company and Announces Inducement Grant Under NYSE Rule 303A.08 (PR Newswire) -6.25%
Sep-17-21 04:01PM	Rafael Holdings Announces Inducement Grant Under NYSE Rule 303A.08 (PR Newswire)
Sep-14-21 08:27AM	Rafael Holdings Appoints Patrick Fabbio as Chief Financial Officer (PR Newswire)
Sep-11-21 04:55PM	INVESTIGATION: Halper Sadeh LLP Investigates GTS, RFL, NLOK, MDLA, STMP, GPX; Shareholders are Encouraged to Contact the Firm (PR Newswire)
Sep-09-21 05:45PM	MERGER ALERT INOV, GNOG, and RFL: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies (ACCESSWIRE)
Sep-04-21 11:47AM	SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates HRC, RAVN, RFL, STMP; Shareholders are Encouraged to Contact the Firm (PR Newswire)
Sep-02-21 12:30PM	MERGER ALERT - GNOG, and RFL: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies (ACCESSWIRE)
Sep-01-21 11:55AM	SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates RFL, SAFM, SNR; Shareholders are Encouraged to Contact the Firm (ACCESSWIRE)
Aug-30-21 04:30PM	NOTICE - IMPORTANT SHAREHOLDER INVESTIGATION UPDATE: Brodsky & Smith Reminds Investors of Investigations Related to the Following Companies: Rafael Holdings, Inc. (NYSE:RFL), American National Group, Inc. (NASDAQ:ANAT), Veoneer, Inc. (NYSE:VNE) (ACCESSWIRE) -8.82%
10:14AM	SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates RFL, CSOD, VICI, SIC; Shareholders are Encouraged to Contact the Firm (GlobeNewswire)
Aug-27-21 11:45AM	MERGER ALERT - GNOG, RFL, and SC: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies (ACCESSWIRE)
Aug-26-21 05:10PM	SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Rafael Holdings, Inc. (NYSE:RFL) (ACCESSWIRE) +9.19%
04:25PM	INVESTIGATION: Halper Sadeh LLP Investigates RFL, FIVN, MDLA, CMO, SNR; Shareholders are Encouraged to Contact the Firm (PR Newswire)
01:24PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Merger of Rafael Holdings, Inc. with Rafael Pharmaceuticals, Inc. (Newsfile)
11:51AM	One Rafael Holdings, Inc. (NYSE:RFL) insider upped their stake by 2,030% in the previous year (Simply Wall St.)
11:20AM	Kaskela Law LLC Announces Investigation of Rafael Holdings, Inc. on Behalf of Stockholders - RFL (ACCESSWIRE)
08:00AM	President and CEO of Rafael Pharmaceuticals, Sanjeev Luther, to Present at the 11th Annual World Orphan Drug Congress USA 2021 (GlobeNewswire)
Aug-25-21 10:00AM	Rafael Pharmaceuticals Announces the Successful Completion of Phase 1b Clinical Trial and Initiates Phase 2 for CPI-613® (devimistat) in Combination with Gemcitabine and Cisplatin in Patients with Biliary Tract Cancer (GlobeNewswire) +18.49%
Aug-24-21 04:01PM	Rafael Holdings Announces Closing of $104.2 Million Private Placement (PR Newswire) -6.74%
11:30AM	SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Rafael Holdings, Inc. (NYSE - RFL) (ACCESSWIRE)
Aug-20-21 07:00AM	Rafael Holdings Announces $104.2 Million Private Placement (PR Newswire) -13.15%
Aug-19-21 04:17PM	ALERT: Halper Sadeh LLP Investigates ALTA, TGRF, RFL, HFC, MNR; Shareholders are Encouraged to Contact the Firm (PR Newswire)
Aug-18-21 11:56AM	SHAREHOLDER ALERT: Rigrodsky Law, P.A. Reminds Investors of Investigation of RIVE, IACB, BCYP, and RFL Mergers (GlobeNewswire)

Rafael Holdings, Inc. owns an interest in clinical and early-stage pharmaceutical companies. It operates through the following segments: Healthcare, Infusion Technology, and Real Estate. The Healthcare segment relates to the activities of LipoMedix, Barer, Farber, and Rafael Medical Devices. The Infusion Technology segment manages equity interest on Day Three. The Real Estate segment refers to the company's real estate holdings. The company was founded in 2017 and is headquartered in Newark, NJ.

CEOMr. Howard S. Jonas

Chief Financial OfficerMr. David A. Polinsky Esq.

Chief Operating OfficerMr. Joshua M. Fine

Corporate SecretaryMs. Joyce J. Mason Esq.

ZDGE

Zedge Inc

RFL

Rafael Holdings Inc

Upgrade your Finviz experience